EU Secondary Data Post-Authorisation Safety Study of AZD1222

Trial Identifier: D8111R00006
Sponsor: AstraZeneca
RTI Health Solutions
NCTID:: NCT05126992
Start Date: February 2022
Primary Completion Date: October 2023
Study Completion Date: October 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy, Firenze Firenze, Italy, 50141
Netherlands, Utrecht Utrecht, Netherlands, 3528 AE
Spain, Barcelona Barcelona, Spain, 8007
Spain, Valencia Valencia, Spain, 46020
United Kingdom, Southampton Southampton, United Kingdom, SO31 1AA